E09.351
Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code E09.351 refers to a specific type of diabetes mellitus caused by the use of certain drugs or chemicals. This form of diabetes is characterized by high blood sugar levels and can lead to serious eye complications, including proliferative diabetic retinopathy with macular edema. It is important to recognize and manage this condition promptly to prevent long-term health issues.
Causes & Symptoms
Clinical Causes: Use of certain medications such as thiazide diuretics, glucocorticoids, or atypical antipsychotics Exposure to industrial chemicals or toxins Reactions to specific drugs causing pancreatic beta-cell dysfunction Prolonged or high-dose treatment with drugs that impair glucose metabolism
Key Symptoms: Increased thirst and frequent urination Unexplained weight loss or gain Blurry vision or visual disturbances Fatigue and weakness Signs of eye disease, such as floaters or dark spots Swelling or pain in the eyes, if retinopathy progresses
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves blood tests to measure blood glucose levels and hemoglobin A1c. Eye examinations, including retinal imaging, help identify diabetic retinopathy and macular edema. Healthcare providers also review medication history to determine if drugs or chemicals may have contributed to the condition.
Treatment Protocols: Management focuses on controlling blood sugar levels through a combination of lifestyle changes and medication adjustments. Addressing the eye condition may involve laser therapy, injections, or other ophthalmologic procedures to reduce retinal swelling and prevent vision loss. Discontinuing or substituting the offending drug may be necessary under medical supervision.
Clinical Advice & FAQs
Billing Guidance
Is E09.351 a billable ICD-10 code?
Yes, E09.351 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E09.351?
Clinical documentation must specify the nature of Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema and any associated comorbidities for accurate reporting.
Cite this Clinical Reference